Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
5 May 23
ARS
2022 FY
Annual report to shareholders
18 Apr 23
10-K
2022 FY
Annual report
22 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
24 Feb 22
Current reports
8-K
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
28 Feb 24
8-K
Regulation FD Disclosure
13 Dec 23
8-K
Regulation FD Disclosure
11 Dec 23
8-K
Departure of Directors or Certain Officers
22 Nov 23
8-K
Editas Medicine Announces Third Quarter 2023 Results and Business Updates
3 Nov 23
8-K
Departure of Directors or Certain Officers
10 Oct 23
8-K
Editas Medicine Announces Second Quarter 2023 Results and Business Updates
2 Aug 23
8-K
Editas Medicine Announces Offering of Common Stock
15 Jun 23
8-K
Regulation FD Disclosure
9 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
5 Jun 23
Registration and prospectus
S-3ASR
Automatic shelf registration
28 Feb 24
S-8
Registration of securities for employees
28 Feb 24
424B5
Prospectus supplement for primary offering
15 Jun 23
424B5
Prospectus supplement for primary offering
14 Jun 23
S-8
Registration of securities for employees
22 Feb 23
S-8
Registration of securities for employees
24 Feb 22
424B5
Prospectus supplement for primary offering
14 May 21
S-8
Registration of securities for employees
1 Mar 21
S-3ASR
Automatic shelf registration
1 Mar 21
424B5
Prospectus supplement for primary offering
21 Jan 21
Proxies
DEFA14A
Additional proxy soliciting materials
16 Apr 24
DEF 14A
Definitive proxy
16 Apr 24
DEFA14A
Additional proxy soliciting materials
18 Apr 23
DEF 14A
Definitive proxy
18 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
DEFA14A
Additional proxy soliciting materials
21 May 21
DEFA14A
Additional proxy soliciting materials
20 Apr 21
DEF 14A
Definitive proxy
20 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 20
Other
CT ORDER
Confidential treatment order
15 Oct 21
CT ORDER
Confidential treatment order
13 Jul 21
SEC STAFF
SEC staff action: Order
23 Mar 21
SEC STAFF
SEC staff action: Order
23 Feb 21
CT ORDER
Confidential treatment order
27 Apr 20
CT ORDER
Confidential treatment order
26 Dec 19
CT ORDER
Confidential treatment order
24 Oct 19
SEC STAFF
SEC staff action: Order
26 Sep 19
SEC STAFF
SEC staff action: Order
23 Sep 19
CT ORDER
Confidential treatment order
25 Oct 18
Ownership
SC 13G/A
STATE STREET CORP
10 Apr 24
4
Erick Lucera
5 Mar 24
4
Linda Burkly
5 Mar 24
4
Gilmore Neil O'Neill
5 Mar 24
4
Baisong Mei
5 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
SC 13G/A
Deep Track Capital, LP
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
24 Jan 24
SC 13G/A
STATE STREET CORP
10 Jan 24